<DOC>
	<DOCNO>NCT00004310</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate efficacy intravenous versus oral pulse load clomipramine ( CMI ) follow 12-week course maintenance therapy patient obsessive compulsive disorder .</brief_summary>
	<brief_title>Phase II Randomized Study Intravenous Versus Oral Clomipramine Patients With Obsessive Compulsive Disorder</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , multicenter study . Patients stratify participate institution . Patients randomize one two treatment arm . Arm I : Patients receive pulse load dose clomipramine ( CMI ) IV oral placebo day 1 2 . Arm II : Patients receive oral pulse load dose CMI IV placebo day 1 2 . Patients receive maintenance therapy daily oral CMI 12 week begin 4 day pulse load .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Clomipramine</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Primary diagnosis obsessive compulsive disorder ( OCD ) least 1 year Meets Diagnostic Statistical Manual ( DSMIV ) criterion structure clinical interview YaleBrown ObsessiveCompulsive Scale ( YBOCS ) score least 20 At least 12 obsession compulsion present Secondary diagnosis major depression eligible : Meets DSMIV criterion Onset occur OCD OCD primary diagnosis dominate clinical picture Excluded diagnosis : Organic mental disorder Principal psychiatric disorder OCD Bipolar disorder Schizophrenia Posttraumatic stress disorder Tics Tourette 's syndrome Body dysmorphic disorder Delusional disorder Borderline schizotypal personality disorder Anorexia nervosa Bulimia nervosa Panic disorder Panic attack Must fail least 2 prior regimen serotonin reuptake inhibitor therapy Prior/Concurrent Therapy Endocrine therapy : Concurrent thyroid medication allow stable least 3 month At least 2 week since prior systemic corticosteroid Surgery : No prior psychosurgery neurosurgery Other : At least 3 month since prior electroconvulsive insulin shock therapy At least 6 week since prior fluoxetine At least 30 day since prior investigational drug At least 2 week since follow : Neuroleptics ( 6 week since depot neuroleptic ) Nondepot antipsychotic Anxiolytics Stimulants Barbiturates Antidepressants ( 4 week since monoamine oxidase inhibitor ) At least 2 week since prior anticonvulsant No concurrent antipsychotics No concurrent antihypertensives , e.g. , guanethidine clonidine No concurrent behavior therapy Patient Characteristics Hematopoietic : No anemia No druginduced leukopenia No bleeding disorder No blood dyscrasia bone marrow depression Hepatic : Liver function test great twice normal No hepatic abnormality Renal : No renal abnormality , e.g. , urinary retention Cardiovascular : No cardiac abnormality , e.g . : Congestive heart failure Myocardial infarction Cardiac conduction disturbance firstdegree heart block Electrocardiogram significant abnormality No hypertension Pulmonary : No pulmonary abnormality Other : No hypersensitivity prior severe adverse experience clomipramine No medical contraindication serotonin reuptake inhibitor tricyclic antidepressant No history seizures risk seizure , i.e . : No family history epilepsy No birth trauma No significant head trauma No meningitis encephalitis No subarachnoid hemorrhage No episodes unconsciousness , include syncope No prostatic hypertrophy No narrowangle glaucoma , i.e. , intraocular pressure great 22 mm Hg No uncontrolled hyperthyroidism No clinically significant abnormality , e.g . : Neurologic Metabolic Gastrointestinal Autoimmune No substantial risk suicide At least 6 month since drug alcohol abuse dependence No illiteracy No Intelligence Quotient 80 No plan blood donation study Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>anxiety disorder</keyword>
	<keyword>disease-related problem/condition</keyword>
	<keyword>neurologic psychiatric disorder</keyword>
	<keyword>obsessive compulsive disorder</keyword>
	<keyword>oncologic disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>